Nitric oxide and ocular blood flow in patients with IDDM. - Wikidata - awgldk - TriplyDB

Nitric oxide and ocular blood flow in patients with IDDM.

Nitric oxide and ocular blood flow in patients with IDDM.

http://www.wikidata.org/entity/Q36850999

about

Dominant role of an endothelium-derived hyperpolarizing factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eye Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells Expression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and regulation by nitric oxide and oxidative stress Evaluation of the Zeiss retinal vessel analyser.Ocular haemodynamics and colour contrast sensitivity in patients with type 1 diabetes.Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans.Nitric oxide regulates retinal vascular tone in humans.A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization.The pathogenesis of edema in diabetic maculopathy.Review: taurine: a "very essential" amino acid.Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients Exhaled NO during graded changes in inhaled oxygen in man Hypertensive retinopathy revisited: some answers, more questions.Exogenous L-arginine does not affect angiotensin II-induced renal vasoconstriction in man.Downregulation of reduced-folate transporter by glucose in cultured RPE cells and in RPE of diabetic mice Expression, subcellular localization, and regulation of sigma receptor in retinal muller cells.Impaired retinal vasodilator responses in prediabetes and type 2 diabetes.Regulation of reduced-folate transporter-1 in retinal pigment epithelial cells by folate.Analysis of sigma receptor (sigmaR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice.The Role of Sigma1R in Mammalian Retina.Compensatory Vasodilator Mechanisms in the Ophthalmic Artery of Endothelial Nitric Oxide Synthase Gene Knockout Mice.Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles.Diabetic Retinopathy and the NMDA Receptor.Nitric oxide synthase in gingival tissues of patients with chronic periodontitis and with and without diabetes.Treatment of vascular retinopathies with Pycnogenol.Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system.Changes of central retinal artery blood flow and endothelial function in patients with coronary artery disease.Insulin is a key determinant of elevated retinal arteriolar flicker response in insulin-resistant individuals.

P2860

Q28362100-F95FCF0C-44A1-46CD-9B10-909504100EDD Q28363533-59A5A130-778E-4997-BADB-79E8FAFE15D6 Q28580237-A9722258-14F2-4EB6-984B-789D0E8DF4FF Q30657401-791CB19A-3560-44E3-BB15-3D1544ADD530 Q30862876-904322C5-A222-4046-A70F-31874D74B7DC Q30925858-63BC3805-1156-44F6-962C-88FA405249C7 Q31142175-14F5D2E9-1787-46E2-B46F-4AFA77EFFF84 Q33269618-5B30F84D-EC38-4E7C-83B2-C5C538B76699 Q33887327-DBE9ED50-398C-4A52-B8A7-959544A0B30D Q34312980-8F0FD0A9-C157-46EB-98F0-9CE1D1B03782 Q34960671-6A8D9A3A-FDE9-4810-BB8B-6FF4E4E15DC9 Q35563782-21340879-C361-4BDC-B4C1-C6899F02F99C Q35594054-52DDB9F9-B089-438E-9516-B6E82CC1A615 Q35803117-9C2FA7D8-BF65-441D-98C0-07F7BD11AE61 Q36266331-786B2E22-F9DC-4359-894E-F7B299895018 Q37047868-8F076772-88C4-4010-AA48-DFD51ED3238C Q37110310-A5AD5A1B-ED51-407E-A459-9B5322C54274 Q37172802-F57CE067-6D0B-4D59-A505-C4F5C7CE7C32 Q37172896-ABF41CC5-7006-4789-8A76-35F222F24BFC Q38896659-124DFA90-CAE7-4B33-9EC7-9C0561A23E0C Q41221957-528D41FC-B552-4FC8-A146-D9F7C0C0385C Q42427172-3680A8BC-4B73-4C56-A6FD-82D1C97D04A8 Q42618396-AB0AA73F-7246-4D45-9712-FFF98BDABA1D Q43199257-072D16CB-6EB0-4731-9835-89BDFB8D52E2 Q43606567-A2FBB903-A163-4F0C-9145-72C4F1DEEF7F Q43917419-0B1D171D-07EE-47AE-B4C1-A46DCE8B444E Q46990941-0B633382-07A1-4CA0-80A8-152CDEF7F55B Q51302547-BBF46CB2-4433-49A7-8878-6E28EABC1D2A

P2860

Nitric oxide and ocular blood flow in patients with IDDM.

http://www.wikidata.org/entity/Q36850999

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Nitric oxide and ocular blood flow in patients with IDDM.

@en

type

label

Nitric oxide and ocular blood flow in patients with IDDM.

@en

prefLabel

Nitric oxide and ocular blood flow in patients with IDDM.

@en

P1433

Q36850999-CF980D29-A0E4-4283-9D97-E3E1D1A37BEE

P1476

Q36850999-5292E78D-6B2E-428E-8E3D-13D121B169F3

P2093

Q36850999-1A87408A-06DF-49FD-A905-1D2B52F57D30

Q36850999-2D6DF4F1-4237-4027-A668-F2E3DCBA0E8B

Q36850999-510BBB73-735A-4E04-9FB0-B95B890D4ECE

Q36850999-5DCD6699-0C22-4775-B9F8-DB33B61CE49B

Q36850999-798BE217-F148-42DF-AE62-CB282ED34123

Q36850999-B22E2580-8407-45AC-B261-1BF81332DD8A

Q36850999-B255C459-77CA-49B8-8428-6A47558D0DE9

Q36850999-D9112251-2FFE-4626-B951-63CC60C80C52

Q36850999-E835AA9A-E62F-4613-B2E8-7485150E552A

P304

Q36850999-31B7A03B-72F8-4089-9909-FB59C370948B

P31

Q36850999-81EECAB7-9B03-4B45-AC1A-9FD5028FA111

P356

Q36850999-795E9F95-D68F-4B0F-8D84-74D106CA0376

P407

Q36850999-8BCBD7A5-0869-4F68-A1CD-AAEAD645852D

P433

Q36850999-55EC67C7-2D2A-4FF9-95F1-4F9425B36E1C

P478

Q36850999-CB1A6361-4317-4BF9-8ECF-526B20711767

P577

Q36850999-55C37F9C-47AF-461F-90AA-C37BAD6C74DA

P698

Q36850999-F75AA4C0-807B-41AB-BAF2-88AA4DD4BA39

P356

P1433

P1476

Nitric oxide and ocular blood flow in patients with IDDM.

@en

P2093

Adam H

http://www.w3.org/2001/XMLSchema#string

Breiteneder H

http://www.w3.org/2001/XMLSchema#string

Eichler HG

http://www.w3.org/2001/XMLSchema#string

Fasching P

http://www.w3.org/2001/XMLSchema#string

Ferber W

http://www.w3.org/2001/XMLSchema#string

Findl O

http://www.w3.org/2001/XMLSchema#string

Schmetterer L

http://www.w3.org/2001/XMLSchema#string

Strenn K

http://www.w3.org/2001/XMLSchema#string

Wolzt M

http://www.w3.org/2001/XMLSchema#string

P304

653-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIAB.46.4.653

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

1997-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9075807

http://www.w3.org/2001/XMLSchema#string